Medline boost syringe stock with BD to maintain 45-day inventory, improving supply chain resilience amid FDA import restrictions on China-made syringes.

FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S.

Becton Dickinson ($BDX) is buying California's Safety Syringes, a maker of anti-needlestick devices, looking to bolster its injectable offerings. BD didn't disclose ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today issued the following statement regarding the March 19, ...

FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper. FDA alerted healthcare ...

As reported by Digital Journal, medicines held in 3 milliliter (ml) and 5ml syringes manufactured by Becton-Dickinson (BD) were deemed to be unsuitable because medicines held in these types of ...

Lest this week’s news about FDA cautioning against the use of plastic syringes made in China raise concerns of a possible shortage, BD announced today that it is increasing its US production of ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...

As Pfizer, BioNTech, Moderna and now AstraZeneca rack up emergency authorizations for their COVID-19 vaccines, the world is racing to get shots shipped out and into patients’ arms. A slew of injection ...